I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 5 studies | 23% ± 5% | |
| epithelial cell | 5 studies | 34% ± 18% | |
| plasmablast | 4 studies | 42% ± 14% | |
| endothelial cell | 4 studies | 20% ± 3% | |
| classical monocyte | 3 studies | 36% ± 15% | |
| non-classical monocyte | 3 studies | 34% ± 15% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 28% ± 1% | |
| hematopoietic precursor cell | 3 studies | 36% ± 9% | |
| myeloid cell | 3 studies | 34% ± 6% | |
| ciliated cell | 3 studies | 34% ± 10% | |
| dendritic cell | 3 studies | 39% ± 27% | |
| intestinal crypt stem cell | 3 studies | 19% ± 3% | |
| erythroblast | 3 studies | 46% ± 20% |
